Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Uterine hyperstimulation"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Medicina, Vol 57, Iss 5, p 478 (2021)
The PROPESS, a controlled-release dinoprostone vaginal delivery system, is a pharmacological cervical ripening intervention and promotes cervical change causing uterine contraction. During insertion of the PROPESS, uterine hyperstimulation could occu
Externí odkaz:
https://doaj.org/article/88f463bc1296419d8c27af25d149e3e3
Publikováno v:
Best Practice & Research Clinical Obstetrics & Gynaecology. 77:42-52
Worldwide, there has been a trend toward later motherhood. Concurrently, the incidence of subfertility has been on the rise, necessitating conception using assisted reproductive technologies (ARTs). These pregnancies are considered high risk due to f
Induced labour with prostaglandin E2 in different parity groups after premature rupture of membranes
Autor:
A A Sobande, H M Albar
Publikováno v:
Eastern Mediterranean Health Journal. 9:309-315
The study compared the outcome of induction of labour with prostagl and in E2 vaginal tablets in patients with premature rupture of membranes [PROM] at term in different parity groups. A retrospective review was made of the hospital records of 169 wo
Autor:
L Hellmeyer, E Schalinski, Jens-Peter Scharf, Ute Jarchau, Josefine Theresia Koenigbauer, Werner Rath, Sandra C. Klaucke, Ulrich Gauger, Katrin Brandt
Publikováno v:
Journal of Perinatal Medicine. 49:797-805
Objectives Worldwide, the overall cesarean section is rising. Trial of labor after cesarean (TOLAC) is an overall safe option with an immediate impact on neonatal and maternal short- and long-term health. Since the use of prostaglandins in cervical r
Publikováno v:
Geburtshilfe und Frauenheilkunde
As the number of labor inductions in high-income countries has steadily risen, hospital costs and the additional burden on obstetric staff have also increased. Outpatient induction of labor is therefore becoming increasingly important. It has been es
Publikováno v:
Al-Azhar Medical Journal. 50:299-310
Background: Oxytocin is an effective commonly used drug for induction of labor, However it is associated with several maternal and neonatal adverse effect. So, controlled dosage is recommended. Objective: To determine the effect of continuation or di
Autor:
Rehab Abdelhamid Aboshama, Mohammad Sunoqrot, Mohamed Sobhy Bakry, Nourhan M. Alborno, Abdulhadi A. AlAmodi, Mohamed Gadelkarim, Mohammad Abrar Shareef, Ahmed Mohamed Abdelhakim, Ahmed M. Abbas
Publikováno v:
Journal of Perinatal Medicine. 49:178-190
Objectives To compare the safety and efficacy between high dose and low dose oxytocin administration for labor augmentation. Methods We searched for the available studies during March 2020 in PubMed, Cochrane Library, Scopus, and ISI Web of science.
Autor:
Peter Schwaerzler, Hendrik Hasselbeck, Timm F. Döbert, Aleke Brandstetter, Wolfgang Henrich, Moritz Döbert
Publikováno v:
Journal of Perinatal Medicine. 48:488-494
ObjectiveTo compare the safety of misoprostol vaginal insert (MVI) for labor induction using standard and adjusted criteria.MethodsThis was a single-center, comparative cohort study of 138 pregnant women ≥37/0 weeks undergoing labor induction with
Autor:
Yasuhiro Teishikata, Sho Takakura, Kayo Tanaka, Naosuke Enomoto, Hiroaki Tanaka, Shintaro Maki, Tadashi Maezawa, Asa Kitamura, Mizuki Yamaguchi, Tomoaki Ikeda
Publikováno v:
The journal of obstetrics and gynaecology researchReferences. 47(12)
Aim This study aimed to compare the efficacy and safety of a controlled-release dinoprostone vaginal delivery system (PROPESS) and a metreurynter for labor induction. Methods This retrospective case-controlled study included 117 pregnant women (51 an